首页> 外文OA文献 >Purinergic P2 receptors trigger adenosine release leading to adenosine A2A receptor activation and facilitation of long-term potentiation in rat hippocampal slices
【2h】

Purinergic P2 receptors trigger adenosine release leading to adenosine A2A receptor activation and facilitation of long-term potentiation in rat hippocampal slices

机译:嘌呤能p2受体触发腺苷释放,导致腺苷a2a受体激活并促进大鼠海马脑片的长时程增强

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Electrophysiological recordings were used to investigate the effects of ATP analogues on [theta]-burst-induced long-term potentiation (LTP) in rat hippocampal slices. [alpha],[beta]-Methylene ATP ([alpha],[beta]-MeATP; 20 [mu]M) decreased LTP from 36±9% to 17±5%, an effect prevented by adenosine A1 receptor blockade in accordance with the localised catabolism of ATP analogues into adenosine, leading to adenosine A1 receptor activation. Thus, to probe the role of extracellular ATP, all experiments were performed with the A1 receptor selective antagonist, 1,3-dipropyl-8-cyclopentylxanthine (50 nM). In these conditions, [alpha],[beta]-MeATP or 5'-adenylylimido-diphosphate ([beta],[gamma]-ImATP; 20 [mu]M) facilitated LTP by 120%, an effect prevented by the P2 receptor antagonists, pyridoxalphosphate-6-azophenyl-2'-4'-disulphonic acid (PPADS; 20 [mu]M) or suramin (75 [mu]M), as well as by the P2X1/3-selective antagonist 8-(benzamido)naphthalene-1,3,5-trisulfonate (10 [mu]M). The facilitations of LTP by either [alpha],[beta]-MeATP or [beta],[gamma]-ImATP (20 [mu]M) were also prevented by both 4-(2-[7-amino-2-(2-furyl(1,2,4)-triazolo(2,3a)-(1,3,5)triazin-5-yl-amino]ethyl)phenol (50 nM) or 7-2(-phenylethyl)-5-amino-2-(2-furyl)-pyrazolo-[4,3-e]-1,2,4-triazolo[1,5-c] pyrimidine (50 nM), antagonists of facilitatory adenosine A2A receptors, were occluded by the A2A receptor agonist, CGS 21680 (10 nM) and were prevented by the protein kinase C inhibitor, chelerythrine (6 [mu]M) and unaffected by the protein kinase A inhibitor, H89 (1 [mu]M). Furthermore, [beta],[gamma]-ImATP (20 [mu]M) enhanced [3H]adenosine outflow from rat hippocampal slices by nearly 150%, an effect prevented by PPADS (20 [mu]M) or suramin (75 [mu]M). The adenosine transport inhibitors, nitrobenzylthioinosine (5 [mu]M) and dipyridamole (10 [mu]M) also prevented [beta],[gamma]-ImATP (20 [mu]M)-induced [3H]adenosine outflow and facilitation of LTP. These results suggest that ATP analogues facilitate LTP through P2 receptor activation that mainly triggers adenosine release leading to the activation of adenosine A2A receptors.
机译:使用电生理记录来研究ATP类似物对大鼠海马切片中θ-爆发诱导的长期增强(LTP)的影响。 α,β-亚甲基ATP(α,β-MeATP;20μM)使LTP从36±9%降低至17±5%,该作用被腺苷A1受体阻滞剂阻止。 ATP类似物的局部分解代谢为腺苷,导致腺苷A1受体活化。因此,为探究细胞外ATP的作用,所有实验均使用A1受体选择性拮抗剂1,3-二丙基-8-环戊基黄嘌呤(50nM)进行。在这些条件下,α,β-MeATP或5'-腺苷酰二磷酸(β,γ-ImATP; 20μM)促进LTP达到120%,P2受体阻止了这种作用拮抗剂吡pyr醛磷酸盐-6-偶氮苯基-2'-4'-二磺酸(PPADS; 20μM)或苏拉明(75μM)以及P2X1 / 3选择性拮抗剂8-(苯甲酰胺)萘-1,3,5-三磺酸盐(10μM)。两种4-(2- [7-氨基-2-(-)对α,β-MeATP或β,γ-ImATP(20μM)对LTP的促进作用也被阻止。 2-呋喃基(1,2,4)-三唑并(2,3a)-(1,3,5)三嗪-5-基-氨基]乙基)苯酚(50nM)或7-2(-苯乙基)-5闭塞了-amino-2-(2-furyl)-pyrazolo- [4,3-e] -1,2,4-triazolo [1,5-c]嘧啶(50nM),是促进腺苷A2A受体的拮抗剂被A2A受体激动剂CGS 21680(10nM)所阻止,并被蛋白激酶C抑制剂白屈菜红碱(6μM)所阻止,并且不受蛋白激酶A抑制剂H89(1μM)的影响。 β,γ-ImATP(20μM)使大鼠海马切片的[3H]腺苷流出增加了近150%,PPADS(20μM)或苏拉明(75μm)阻止了这种作用M)。腺苷转运抑制剂,硝基苄基硫代肌苷(5μM)和双嘧达莫(10μM)也阻止了β,γ-ImATP(20μM)诱导的[3H]腺苷外流和促进LTP。这些结果表明ATP类似物有助于通过主要触发腺苷释放的P2受体激活来抑制LTP,从而导致腺苷A2A受体激活。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号